**Core Concept:** Osteopenia is a condition characterized by a decrease in bone mineral density, making bones weak and fragile. It increases the risk of fractures. Lupus nephritis is a complication of systemic lupus erythematosus (SLE) that affects the kidneys. Medications used to treat SLE may also have adverse effects on bone health and increase the risk of fractures.

**Why the Correct Answer is Right:**

In this question, we are looking for the medication that contributed to the patient's fractures. The correct answer involves medications that can cause osteopenia, leading to fractures. The patient has marked osteopenia on examination and radiograph, which explains the fractures.

Corticosteroids are commonly used in the treatment of SLE, including patients with lupus nephritis. However, they are known to cause osteopenia, leading to an increased risk of fractures.

**Why Each Wrong Option is Incorrect:**

A. Azathioprine (Option A) is an immunosuppressive drug used in the treatment of lupus nephritis. While it can cause gastrointestinal side effects, it is less likely to cause osteopenia and fractures compared to corticosteroids.

B. Hydroxychloroquine (Option B) is an antimalarial drug used in the treatment of SLE. Although it has some adverse effects, osteopenia and fractures are less common than with corticosteroids.

C. Calcitonin (Option C) is a hormone that regulates calcium homeostasis and is rarely used in clinical practice. Although it can cause osteoporosis, it is less likely to cause fractures compared to corticosteroids.

D. Calcitriol (Option D) is a form of vitamin D used to regulate calcium and phosphorous levels. While it can cause hypercalcemia, fractures are less likely than with corticosteroids.

**Clinical Pearl:**

Patients on long-term corticosteroid therapy should undergo regular monitoring of bone density to prevent or detect osteopenia and fractures. Osteopenia can occur at doses as low as 5 mg/day of prednisolone or its equivalent. In the case of lupus nephritis, the choice of alternative immunosuppressive agents like mycophenolate mofetil, azathioprine, or cyclophosphamide should be considered to reduce corticosteroid-induced osteopenia and fractures.

**Correct Answer: D. Calcitriol (Option D)**

Calcitriol (active form of vitamin D) is not directly associated with increased risk of fractures. While it may cause hypercalcemia (high blood calcium levels), the risk of fractures is generally lower than corticosteroids. As mentioned earlier, corticosteroids are the most likely cause of the patient's osteopenia and fractures due to their direct detrimental effect on bone density.